Extensive degradation of myelin basic protein isoforms by calpain following traumatic brain injury

Axonal injury is one of the key features of traumatic brain injury (TBI), yet little is known about the integrity of the myelin sheath. We report that the 21.5 and 18.5‐kDa myelin basic protein (MBP) isoforms degrade into N‐terminal fragments (of 10 and 8 kDa) in the ipsilateral hippocampus and cortex between 2 h and 3 days after controlled cortical impact (in a rat model of TBI), but exhibit no degradation contralaterally. Using N‐terminal microsequencing and mass spectrometry, we identified a novel in vivo MBP cleavage site between Phe114 and Lys115. A MBP C‐terminal fragment‐specific antibody was then raised and shown to specifically detect MBP fragments in affected brain regions following TBI. In vitro naive brain lysate and purified MBP digestion showed that MBP is sensitive to calpain, producing the characteristic MBP fragments observed in TBI. We hypothesize that TBI‐mediated axonal injury causes secondary structural damage to the adjacent myelin membrane, instigating MBP degradation. This could initiate myelin sheath instability and demyelination, which might further promote axonal vulnerability.

[1]  H. Berlet,et al.  Elucidation of cathepsin B‐like activity associated with extracts of human myelin basic protein , 1985, FEBS letters.

[2]  G. Clifton,et al.  Immunohistochemical study of calpain-mediated breakdown products to alpha-spectrin following controlled cortical impact injury in the rat. , 1997, Journal of neurotrauma.

[3]  N. Banik,et al.  Mechanism of Myelin Breakdown in Experimental Demyelination: A Putative Role for Calpain , 2001, Neurochemical Research.

[4]  N. Banik,et al.  Peptide bond specificity of calpain: Proteolysis of human myelin basic protein , 1994, Journal of neuroscience research.

[5]  Irving Ea,et al.  Assessment of white matter injury following prolonged focal cerebral ischaemia in the rat. , 2001 .

[6]  R. Talanian,et al.  Simultaneous Degradation of αII- and βII-Spectrin by Caspase 3 (CPP32) in Apoptotic Cells* , 1998, The Journal of Biological Chemistry.

[7]  D. Graham,et al.  Calpain activation and cytoskeletal protein breakdown in the corpus callosum of head-injured patients. , 1999, Journal of neurotrauma.

[8]  M. Benuck,et al.  Metabolic instability of myelin proteins. Breakdown of basic protein induced by brain cathepsin D. , 1975, European journal of biochemistry.

[9]  D. Attwell,et al.  NMDA receptors are expressed in oligodendrocytes and activated in ischaemia , 2005, Nature.

[10]  J. Morrow,et al.  Development and characterization of antibodies specific to caspase-3-produced alpha II-spectrin 120 kDa breakdown product: marker for neuronal apoptosis , 2000, Neurochemistry International.

[11]  K. Wang,et al.  Development and therapeutic potential of calpain inhibitors. , 1997, Advances in pharmacology.

[12]  M. Schwab,et al.  Sequential loss of myelin proteins during Wallerian degeneration in the rat spinal cord , 2003, Glia.

[13]  J. A. Sloane,et al.  Age‐dependent myelin degeneration and proteolysis of oligodendrocyte proteins is associated with the activation of calpain‐1 in the rhesus monkey , 2002, Journal of neurochemistry.

[14]  M. Fini,et al.  Effects of Matrix Metalloproteinase-9 Gene Knock-Out on Morphological and Motor Outcomes after Traumatic Brain Injury , 2000, The Journal of Neuroscience.

[15]  Helen M. Bramlett,et al.  Quantitative structural changes in white and gray matter 1 year following traumatic brain injury in rats , 2002, Acta Neuropathologica.

[16]  T. Miyatake,et al.  Myelin‐Associated Calpain II , 1988, Journal of neurochemistry.

[17]  J. Bresnahan,et al.  Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys , 1997, Nature Medicine.

[18]  K. Williams,et al.  Acidic lipids enhance cathepsin D cleavage of the myelin basic protein , 1986, Journal of neuroscience research.

[19]  S. Brostoff,et al.  Specific cleavage of the A1 protein from myelin with cathepsin D. , 1974, The Journal of biological chemistry.

[20]  K. Takahashi,et al.  Limited proteolysis of bovine myelin basic protein by calcium-dependent proteinase from bovine spinal cord. , 1989, Journal of biochemistry.

[21]  P. Stys,et al.  Anoxic and Ischemic Injury of Myelinated Axons in CNS White Matter: From Mechanistic Concepts to Therapeutics , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  T. Yamashima,et al.  Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA‐074: a novel strategy for neuroprotection based on ‘calpain–cathepsin hypothesis’ , 1998 .

[23]  S. Waxman Demyelinating diseases--new pathological insights, new therapeutic targets. , 1998, The New England journal of medicine.

[24]  M. Esiri,et al.  Axonal damage: a key predictor of outcome in human CNS diseases. , 2003, Brain : a journal of neurology.

[25]  D. Okonkwo,et al.  Caspase-3-mediated cleavage of amyloid precursor protein and formation of amyloid Beta peptide in traumatic axonal injury. , 2002, Journal of neurotrauma.

[26]  A Büki,et al.  Cytochrome c Release and Caspase Activation in Traumatic Axonal Injury , 2000, The Journal of Neuroscience.

[27]  M. Schwab,et al.  Oligodendroglial reaction following spinal cord injury in rat: Transient upregulation of MBP mRNA , 1998, Glia.

[28]  T. Saido,et al.  A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D D Blatter,et al.  Nonspecific white matter degeneration following traumatic brain injury , 1995, Journal of the International Neuropsychological Society.

[30]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .

[31]  M. Benuck,et al.  Specificity of brain cathepsin D: Cleavage of model peptides containing the susceptible phe‐phe regions of myelin basic protein , 1980, Journal of neuroscience research.

[32]  M. Fini,et al.  Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase. , 2002, Journal of neurotrauma.

[33]  B. Pike,et al.  Regional calpain and caspase‐3 proteolysis of α‐spectrin after traumatic brain injury , 1998, Neuroreport.

[34]  D. Johnston,et al.  Neuronal apoptosis inhibitory protein expression after traumatic brain injury in the mouse. , 2001, Journal of neurotrauma.

[35]  J. Trojanowski,et al.  The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury. , 1999, Journal of neuropathology and experimental neurology.

[36]  H. Okano,et al.  Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination , 2003, Neuroscience Research.

[37]  B. Trapp,et al.  NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia , 2006, Nature.

[38]  K. Suzuki,et al.  In situ capture of mu-calpain activation in platelets. , 1993, The Journal of biological chemistry.

[39]  J. Mcdonald,et al.  Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity , 1998, Nature Medicine.

[40]  M Chopp,et al.  Cathepsin B and middle cerebral artery occlusion in the rat. , 1997, Journal of neurosurgery.

[41]  G. Clifton,et al.  A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat , 1997, Neuroscience.

[42]  G. Lynch,et al.  Induction of calpain-mediated spectrin fragments by pathogenic treatments in long-term hippocampal slices. , 1995, The Journal of pharmacology and experimental therapeutics.

[43]  M. Fini,et al.  Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia , 2001, The Journal of Neuroscience.

[44]  J. Povlishock,et al.  Traumatically induced altered membrane permeability: its relationship to traumatically induced reactive axonal change. , 1994, Journal of neurotrauma.

[45]  A. Omori,et al.  Study of expression of myelin basic proteins (MBPs) in developing rat brain using a novel antibody reacting with four major isoforms of MBP , 2002, Journal of neuroscience research.

[46]  Kevin K. W Wang,et al.  Calpain and caspase: can you tell the difference? , 2000, Trends in Neurosciences.

[47]  D. Bozyczko‐Coyne,et al.  Prolonged Calpain‐mediated Spectrin Breakdown Occurs Regionally Following Experimental Brain Injury in the Rat , 1996, Journal of neuropathology and experimental neurology.

[48]  W. Poon,et al.  The pathological spectrum of diffuse axonal injury in blunt head trauma: assessment with axon and myelin stains , 1994, Clinical Neurology and Neurosurgery.

[49]  R. Bullock,et al.  Design and statistical issues in multicenter trials of severe head injury , 2001, Neurological research.

[50]  M. Salter,et al.  NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury , 2005, Nature.

[51]  Kevin K W Wang,et al.  Selective release of calpain produced alphalI-spectrin (alpha-fodrin) breakdown products by acute neuronal cell death. , 2002, Biological chemistry.

[52]  Kevin K W Wang,et al.  Selective Release of Calpain Produced αII-Spectrin (α-Fodrin) Breakdown Products by Acute Neuronal Cell Death , 2002 .

[53]  B. Pike,et al.  Effects of injury severity on regional and temporal mRNA expression levels of calpains and caspases after traumatic brain injury in rats. , 2004, Journal of neurotrauma.

[54]  E. Hogan,et al.  Calcium‐Stimulated Proteolysis in Myelin: Evidence for a Ca2+‐Activated Neutral Proteinase Associated with Purified Myelin of Rat CNS , 1985, Journal of neurochemistry.

[55]  R. Hayes,et al.  Neurofilament 68 and neurofilament 200 protein levels decrease after traumatic brain injury. , 1994, Journal of neurotrauma.

[56]  R. Siman,et al.  Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.